Cwm, LLC Pliant Therapeutics, Inc. Transaction History
Cwm, LLC
- $25.1 Billion
- Q1 2025
A detailed history of Cwm, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 8,525 shares of PLRX stock, worth $13,981. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,525
Previous 607
1304.45%
Holding current value
$13,981
Previous $8,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PLRX
# of Institutions
154Shares Held
62.2MCall Options Held
279KPut Options Held
7.1K-
Tang Capital Management LLC San Diego, CA6MShares$9.84 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.4MShares$8.86 Million0.25% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$8.15 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$5.47 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.05MShares$5 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $79.8M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...